SCHEMBL26324971

SCHEMBL26324971

Cc1ccc(N(c2cccs2)C(C(=O)OC(C)C)C(C)C)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 5/20 0.39
THRB P10828 2/20 0.39
NPC1 O15118 3/20 0.35
RAB9A P51151 3/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
TRPM8 Q7Z2W7 7/20 0.35
HPGD P15428 2/20 0.34
NFKB1 P19838 1/20 0.34
NFKB2 Q00653 1/20 0.34
RELA Q04206 1/20 0.34
TDP1 Q9NUW8 2/20 0.34
ALDH1A1 P00352 3/20 0.34
LMNA P02545 2/20 0.34
KMT2A Q03164 1/20 0.34
GLA P06280 1/20 0.33
TSHR P16473 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
KDM4E B2RXH2 1/20 0.33
MAPK1 P28482 1/20 0.33
POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20564582 0.87 TP53 (0.41) TP53THRBNPC1RAB9ASMN1; SMN2
SCHEMBL26324999 0.84 ALOX5 (0.37) RAB9ATDP1ALDH1A1LMNAKMT2A
SCHEMBL26324940 0.81 TRPM8 (0.39) NPC1RAB9ASMN1; SMN2TRPM8TDP1
SCHEMBL26324989 0.80 HPGD (0.42) TP53NPC1RAB9ASMN1; SMN2HPGD
SCHEMBL26324953 0.77 HSD17B1 (0.40) TP53NPC1RAB9AALDH1A1KMT2A
SCHEMBL26324966 0.75 TP53 (0.37) TP53THRBRAB9ASMN1; SMN2TDP1
SCHEMBL26324996 0.75 ALDH1A1 (0.37) NPC1RAB9ASMN1; SMN2HPGDNFKB1
SCHEMBL26324800 0.73 TSHR (0.42) TP53NPC1RAB9ASMN1; SMN2TDP1
SCHEMBL26327837 0.72 TP53 (0.43) TP53THRBNPC1RAB9ASMN1; SMN2
SCHEMBL25439936 0.72 ALOX5 (0.42) RAB9ATDP1ALDH1A1LMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11767291-B2 Preparation of secondary amines with electrophilic N-linchpin reagents WILLIAM MARSH RICE UNIVERSITY (US) 2023-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11767291-B2 Preparation of secondary amines with electrophilic N-linchpin reagents PNMT, NCL, NPM1 TP53 2601/4885THRB 3828/4885NPC1 2535/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.